{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:35:42Z","timestamp":1785407742207,"version":"3.56.0"},"reference-count":29,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,11,1]]},"DOI":"10.1248\/bpb.b19-00486","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T22:40:03Z","timestamp":1572561603000},"page":"1953-1956","source":"Crossref","is-referenced-by-count":6,"title":["Anti-proliferative Activities of Some Bivalent Symmetrical 5-Substituted Hydantoin Derivatives towards Human Brain Glioma U251 Cells (U251) and Human Carcinoma Cells (KB3-1)"],"prefix":"10.1248","volume":"42","author":[{"given":"Makoto","family":"Furutachi","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Ota","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Fujisaki","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Miyazaki Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Miyazaki Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Miyazaki Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Takeda","sequence":"additional","affiliation":[{"name":"Kagoshima University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Yokomizo","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Rong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Kashige","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Miake","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Sumoto","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Duran AM, Meiler J. Inverted topologies in membrane proteins: a mini-review. <i>Comput. Struct. Biotechnol. J.<\/i>, <b>8<\/b>, e201308004 (2013)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Oshovsky GV, Reinhoudt DN, Verboom W. Supramolecular chemistry in water. <i>Angew. Chem. Int. Ed.<\/i>, <b>46<\/b>, 2366\u20132393 (2007).","DOI":"10.1002\/anie.200602815"},{"key":"3","unstructured":"3) Gibson SE, Castaldi MP. <i>C<\/i><sub>3<\/sub> symmetry: molecular design inspired by nature. <i>Angew. Chem. Int. Ed.<\/i>, <b>45<\/b>, 4718\u20134720 (2006)."},{"key":"4","unstructured":"4) B\u00e9rub\u00e9 G. Natural and synthetic biologically active dimeric molecules: anticancer agents, anti-HIV agents, steroid derivatives and opioid antagonists. <i>Curr. Med. Chem.<\/i>, <b>13<\/b>, 131\u2013154 (2006)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Micewicz ED, Luong HT, Jung C-L, Waring AJ, McBride WH, Ruchala P. Novel dimeric Smac analogs as prospective anticancer agents. <i>Bioorg. Med. Chem. Lett.<\/i>, <b>24<\/b>, 1452\u20131457 (2014).","DOI":"10.1016\/j.bmcl.2014.02.024"},{"key":"6","unstructured":"6) Wermuth CG. <i>The Practice of Medicinal Chemistry<\/i>, 3rd ed., Academic Press, San Diego (2008) and related references cited therein."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Wittmann V. Structural investigation of multivalent carbohydrate-protein interactions using synthetic biomolecules. <i>Curr. Opin. Chem. Biol.<\/i>, <b>17<\/b>, 982\u2013989 (2013).","DOI":"10.1016\/j.cbpa.2013.10.010"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Furutachi M, Fujisaki F, Tsuru R, Ejima A, Gondo T, Goto S, Ito M, Nakamura M, Aki H, Kashige N, Miake F, Sumoto K. Synthesis and antibacterial evaluation of some new 5-substituted hydantoins and novel twin-drug type derivatives. <i>Heterocycles<\/i>, <b>92<\/b>, 1111\u20131120 (2016).","DOI":"10.3987\/COM-16-13453"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Fujisaki F, Furutachi M, Fujiwara R, Okabe M, Aki H, Kashige N, Miake F, Sumoto K. Preparation and antibacterial evaluation of some symmetrical twin-drug type bivalent molecules. <i>Heterocycles<\/i>, <b>91<\/b>, 1668\u20131677 (2015).","DOI":"10.3987\/COM-15-13263"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Fujisaki F, Fujiwara R, Okabe M, Naito A, Fukami E, Aki H, Kashige N, Miake F, Sumoto K. Reaction of 5-methylenehydantoins and their chemical modification to twin-drug type symmetrical molecules. <i>Heterocycles<\/i>, <b>89<\/b>, 2745\u20132759 (2014).","DOI":"10.3987\/COM-14-13106"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Fujisaki F, Aki H, Naito A, Fukami E, Kashige N, Miake F, Sumoto K. Synthesis of new 5-substituted hydantoins and symmetrical twin-drug type hydantoin derivatives. <i>Chem. Pharm. Bull.<\/i>, <b>62<\/b>, 429\u2013438 (2014).","DOI":"10.1248\/cpb.c14-00017"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Fujisaki F, Toyofuku K, Egami M, Ishida S, Nakamoto N, Kashige N, Miake F, Sumoto K. Antibacterial activity of some 5-dialkylaminomethylhydantoins and related derivatives. <i>Chem. Pharm. Bull.<\/i>, <b>61<\/b>, 1090\u20131093 (2013).","DOI":"10.1248\/cpb.c13-00461"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mibu N, Aki H, Ikeda H, Saito A, Uchida W, Yokomizo K, Zhou J-R, Miyata T, Sumoto K. Carbohydrate recognition of symmetrical tripodal receptor type tris(2-aminoethyl)amine derivatives. <i>J. Therm. Anal. Calorim.<\/i>, <b>113<\/b>, 1015\u20131018 (2013).","DOI":"10.1007\/s10973-012-2813-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Mibu N, Ohata T, Sano M, Zhou J-R, Yokomizo K, Aki H, Sumoto K. Carbohydrate recognition of <i>C<\/i><sub>3<\/sub>-symmetrical tripodal receptor-type 2,4,6-trisubstituted 1,3,5-triazine derivatives with antiviral activities. <i>J. Therm. Anal. Calorim.<\/i>, <b>135<\/b>, 2807\u20132811 (2019).","DOI":"10.1007\/s10973-018-7573-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Furutachi M, Ejima A, Tsuru R, Goto S, Gondo T, Ako K, Fuchigami S, Fujii S, Okumura A, Tozuka A, Yokomizo K, Zhou J-R, Inao H, Ono Y, Kashige N, Miake F, Sumoto K. Preparation and biological activity of novel twin-drug type <i>C<\/i><sub>2<\/sub>-symmetrical cyclic phenylboronic acid derivatives. <i>Heterocycles<\/i>, <b>95<\/b>, 517\u2013524 (2017).","DOI":"10.3987\/COM-16-S(S)9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Furutachi M, Ejima A, Tsuru R, Goto S, Gondo T, Ako K, Fujii S, Okumura A, Tozuka A, Yokomizo K, Zhou J-R, Inao H, Ono Y, Kashige N, Miake F, Sumoto K. Novel twin-drug type <i>C<\/i><sub>2<\/sub>-symmetrical phenylboronic acid pinacol esters. <i>Heterocycles<\/i>, <b>92<\/b>, 925\u2013935 (2016).","DOI":"10.3987\/COM-16-13418"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Furutachi M, Fuchigami S, Gondo T, Goto S, Ako K, Sumoto K. Novel trivalent <i>C<\/i>3-symmetrical phenylboronic acid pinacol esters. <i>Org. Prep. Proced. Int.<\/i>, <b>49<\/b>, 287\u2013292 (2017).","DOI":"10.1080\/00304948.2017.1320929"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Furutachi M, Fuchigami S, Ako K, Goto S, Gondo T, Takuse M, Yoshida M, Yokomizo K, Zhou J-R, Matsunaga A, Hiraga N, Kashige N, Miake F, Sumoto K. Novel trivalent <i>C<\/i><sub>3<\/sub>-symmetrical phenylboronic acid pinacol esters and their biological evaluation. <i>Heterocycles<\/i>, <b>96<\/b>, 144\u2013151 (2018).","DOI":"10.3987\/COM-17-13832"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Furutachi M, Matsumoto A, Tamenaga T, Sugita A, Kuroiwa M, Yokomizo K, Zhou J-R, Kashige N, Miake F, Sumoto K. Preparation of novel bivalent linker mode phenylboronic acid derivatives and their biological evaluation. <i>Heterocycles<\/i>, <b>96<\/b>, 1088\u20131100 (2018).","DOI":"10.3987\/COM-18-13899"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Furutachi M, Gondo T, Goto S, Fuchigami S, Ako K, Oowada Y, Yokomizo K, Zhou J-R, Ishizaki T, Koga T, Kashige N, Miake F, Sumoto K. Novel <i>C<\/i><sub>2<\/sub>-symmetrical phenylboronic acid pinacol esters with a few types of linkers and their biological activities. <i>Heterocycles<\/i>, <b>94<\/b>, 1748\u20131758 (2017).","DOI":"10.3987\/COM-17-13745"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Mibu N, Yokomizo K, Sano M, Kawaguchi Y, Morimoto K, Shimomura S, Sato R, Hiraga N, Matsunaga A, Zhou J-R, Ohata T, Aki H, Sumoto K. Preparation and antiviral activity of some new <i>C<\/i><sub>3<\/sub>- and <i>C<sub>S<\/sub><\/i>-symmetrical tri-substituted triazine derivatives having benzylamine substituents. <i>Chem. Pharm. Bull.<\/i>, <b>66<\/b>, 830\u2013838 (2018).","DOI":"10.1248\/cpb.c18-00274"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Mibu N, Yokomizo K, Yamada K, Matsuyama J, Tomonaga S, Sakai I, Sato R, Kawano Y. Matsumoto, Fujita Y, Inoue Y, Iida M, Hashiguchi K, Zhou J-R, Furutachi M, Sumoto K. Preparation of some novel trisubstituted 1,3,5-triazines and hybrid linker mode 1,3,5-triazine derivatives and their biological evaluation. <i>Heterocycles<\/i>, <b>98<\/b>, 489\u2013508 (2019).","DOI":"10.3987\/COM-19-14052"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Furutachi M, Gondo T, Ikeda R, Yoshikawa N, Yokota T, Takeda Y, Yokomizo K, Zhou J-R, Kashige N, Miake F, Sumoto K. Anti-proliferative activities towards human brain glioma U251 cells and human carcinoma cells (KB3-1) of some twin-drug type bivalent <i>C<\/i><sub>2<\/sub>-symmetrical phenylboronic acid derivatives. <i>Biol. Pharm. Bull.<\/i>, <b>42<\/b>, 833\u2013836 (2019).","DOI":"10.1248\/bpb.b18-00859"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Vitale D, Katakam SK, Greve B, Jang B, Oh E-S, Alaniz L, Gotte M. Proteoglycans and glycosaminoglycans as regulators of cancer stem cell function and therapeutic resistance. <i>FEBS J.<\/i>, <b>286<\/b>, 2870\u20132882 (2019).","DOI":"10.1111\/febs.14967"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ikeda R, Vermeulen LC, Lau E, Jiang Z, Sachidanandam K, Yamada K, Kolesar JM. Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells. <i>Int. J. Oncol.<\/i>, <b>38<\/b>, 513\u2013519 (2011).","DOI":"10.3892\/ijo.2010.866"},{"key":"26","unstructured":"26) The Japanese Society of Chemotherapy (1989), <i>Chemotherapy<\/i>, <b>38<\/b>, 102\u2013105 (1990)."},{"key":"27","unstructured":"27) The Japanese Society of Chemotherapy (1992), <i>Chemotherapy<\/i>, <b>41<\/b>, 184\u2013189 (1993)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Schinazi RF, Peters J, Williams C, Chance D, Nahmias AJ. Effect of combinations of acyclovir with vidarabine or its 5\u2032-monophosphate on herpes simplex viruses in cell culture and in mice. <i>Antimicrob. Agents Chemother.<\/i>, <b>22<\/b>, 499\u2013507 (1982).","DOI":"10.1128\/AAC.22.3.499"},{"key":"29","unstructured":"29) Lanzi C, Cassinelli G. Heparan sulfate mimetics in cancer therapy: the challenge to define structural determinants and the relevance of targets for optimal activity. <i>Molecules<\/i>, <b>23<\/b>, 2915 (2018)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/11\/42_b19-00486\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T03:23:42Z","timestamp":1572665022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/11\/42_b19-00486\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00486","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]}}}